ipamorelin cjc1295 without dac blend nasal spray Regenerate (Ipamorelin + Epithalon + CJC-1295 No DAC) CJC-1295 No DAC + Ipamorelin

Across these trials, tesamorelin at 2 mg subcutaneously once daily produced a statistically significant reduction in visceral adipose tissue and waist circumference over 26 weeks, with 26-week extension phases showing that the visceral-fat improvement was maintained on continued treatment and, importantly, without adverse effects on blood glucose or lipid parameters in those analyses

Can be combined for enhanced GH release

As an added benefit, neither CJC-1295 nor Ipamorelin affects other hormones

Preliminary findings indicate that the peptide might have cardioprotective properties, making it a promising candidate for heart disease research